PTPN3 suppresses the proliferation and correlates with favorable prognosis of perihilar cholangiocarcinoma by inhibiting AKT phosphorylation - 30/11/19
, Zongli Zhang a, ⁎ Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 10 |
| Iconographies | 5 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | PTPN3 expression was down-regulated in PHCCA compared with normal bile duct. |
• | Low PTPN3 expression was markedly associated with large tumor size and unfavorable prognosis. |
• | PTPN3 suppressed the proliferation and reduced the G2/S percentages of PHCCA by decreasing AKT phosphorylation. |
• | AKT inhibitor MK-2206 suppressed proliferation and tumor size of PHCCA in vivo. |
Abstract |
Background |
Perihilar cholangiocarcinoma (PHCCA) is the most common type of human cholangiocarcinoma with a very dismal prognosis. Tumor markers and target drugs of PHCCA are desperately needed. Protein phosphatase N3 (PTPN3) has dual roles in the progression of human cancers, but its expression and functions in PHCCA have not been elucidated.
Materials and methods |
The expression of PTPN3 in PHCCA was detected with western blotting, qRT-PCR and immunohistochemistry. The clinical significance of PTPN3 was identified by analyzing the correlations between its expression and the clinicopathological variables, and the prognostic value was evaluated by univariate and multivariate analyses. The functions of PTPN3 in the progression of PHCCA were estimated with both in vitro and in vivo experiments.
Results |
PTPN3 expression was down-regulated in PHCCA compared with normal bile duct. Low PTPN3 expression was markedly associated with large tumor size and unfavorable prognosis. After knocking down PTPN3, the percentages of G2/S phase of PHCCA cells were elevated, and the proliferation increased significantly. Moreover, we demonstrated that the phosphorylation of AKT was elevated by PTPN3 knockdown, and it was required in PTPN3-involved proliferation of PHCCA. Within vivo experiments, PTPN3 and AKT inhibitor MK-2206 were demonstrated to suppress tumor size of PHCCA.
Conclusion |
PTPN3 was a favorable prognostic biomarker of PHCCA. PTPN3 suppressed the proliferation of PHCCA by inhibiting AKT phosphorylation and arresting cell cycle. Our results suggested thatpost-operative detection of PTPN3 would be a helpful approach to stratify the PHCCA patients with high-risk.
Le texte complet de cet article est disponible en PDF.Abbreviations : CCA, PHCCA, AJCC/UICC, TMA, OS, FBS, PBS, IHC, SDS-PAGE, PVDF, qRT-PCR, CCK-8, FACS, AKT
Keywords : PTPN3, Perihilar cholangiocarcinoma, Prognosis, Proliferation, AKT
Plan
Vol 121
Article 109583- janvier 2020 Retour au numéro
Article précédent
- Hsa_circ_0075341 is up-regulated and exerts oncogenic properties by sponging miR-149-5p in cervical cancer
- Shiqing Shao, Chen Wang, Shelian Wang, Hongxia Zhang, Yongyan Zhang
- Tanshinone IIA attenuates silica-induced pulmonary fibrosis via inhibition of TGF-β1-Smad signaling pathway
- Feifei Feng, Nannan Li, Peng Cheng, Huanan Zhang, Hui Wang, Yongbin Wang, Wei Wang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?